Your session is about to expire
← Back to Search
CP1 device for Near-sightedness
Study Summary
This trial will compare the effects of a new light-based therapy device to no treatment at all in slowing the progression of myopia (nearsightedness).
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What is the total expected participation for this research?
"Affirmative. According to clinicaltrials.gov, this medical experiment is actively recruiting patients. It was initially posted on June 23rd 2022 and the latest update took place on June 30th 2022; 45 participants are desired from a single site of recruitment."
Are recruitment efforts underway for this research project?
"Affirmative. Clinicaltrials.gov reports that this clinical trial, which was originally published on June 23rd 2022, is still actively enrolling patients. The study necessitates 45 participants from a single medical centre."
Does this investigation include individuals aged 40 or more?
"The parameters for this research stipulate that the youngest participant must be at least 7 years old while the oldest individual should not exceed 12."
Do I meet the qualifications to participate in this study?
"This research project is looking for 45 young patients aged 7 to 12 with myopia, whose spherical equivalent ranges from -0.50 diopters and -5.50 diopters, and have a visual acuity of 20/25 or higher in both eyes."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger